Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Dose Versus High Dose Stereotactic Spine Radiosurgery for Metastatic Spinal Neoplasms - SHINE: A Prospective Randomized Trial

NCT07039968 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07039968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Dose Versus High Dose Stereotactic Spine Radiosurgery for Metastatic Spinal Neoplasms - SHINE: A Prospective Randomized Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
June 30, 2025
Completion date
June 30, 2035
Enrollment
196 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

spinal neoplasms